Sunshine Biopharma Inc. (SBFM)

Name: Sunshine Biopharma Inc. (SBFM) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Sunshine Biopharma Inc. (SBFM)

Stock Card

$1.14

$0.03 (2.70%)

As on 04-Sep-2026 16:16EDT

Market cap

$4 Mln

Revenue (TTM)

$35 Mln

P/E Ratio

P/B Ratio

0.2

Div. Yield

0 %

Sunshine Biopharma (SBFM) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 1.11 High: 1.14

52 Week Range

Low: 1.01 High: 30.42

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.2 %
ROCE

-- %
Industry P/E

37.91
EV/EBITDA

-7.7
Debt to Equity

0
Book Value

$--
EPS

$-9.9
Face value

--
Shares outstanding

3,877,337

10 Years Aggregate

CFO

$-19.78 Mln

EBITDA

$-25.13 Mln

Net Profit

$-56.66 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Sunshine Biopharma (SBFM)	-90.7	-2.6	-57.1	-92.0	-76.1	-81.4	-67.5
BSE Sensex	-9.6	-2.7	2.9	-5.0	5.4	5.7	10.4
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 04-Sep-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2021	2020	2019
Sunshine Biopharma (SBFM)	-59.0	-44.6	-57.5	345.9	96.3	-97.5
S&P Small-Cap 600	4.0	7.0	13.9	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Sunshine Biopharma (SBFM)	1.1	4.5	35.4	-5.8	-11.0	-23.1	--	0.2
Amneal Pharmaceuticals Inc Class A (AMRX)	17.4	6,074.3	3,117.6	157.4	14.7	--	36.3	186.5
Axsome Therapeutics (AXSM)	206.7	10,826.1	776.6	-191.6	-17.6	-223.4	--	131.0
BridgeBio Pharma (BBIO)	74.8	14,974.8	691.8	-696.2	-89.1	--	--	123.7
Corcept Therapeutics (CORT)	111.6	12,310.3	830.8	54.9	3.2	8.1	264.8	17.9
Dr. Reddy's Laboratories - ADR	12.0	10,020.9	332,834.2	33,166.6	11.1	8.9	29.3	2.5
Elanco Animal Health (ELAN)	24.5	12,236.5	5,020.0	-199.0	1.6	-3	--	1.9
Ligand Pharmaceuticals (LGND)	285.6	5,591.7	290.5	197.2	82.5	19.9	28.9	5.9
Liquidia Technologies Inc (LQDA)	68.7	6,058.9	450.9	138.6	39.1	115.6	50.1	32.1
Twist Bioscience Corp (TWST)	124.7	8,865.6	431.8	-136.7	-30.8	-30.3	--	21.5

Shareholding Pattern

View Details

About Sunshine Biopharma (SBFM)

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is... developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida. Read more

CFO & Secretary

Mr. Camille Sebaaly
CFO & Secretary

Mr. Camille Sebaaly
Headquarters

Fort Lauderdale, FL
Website

https://sunshinebiopharma.com

FAQs for Sunshine Biopharma (SBFM)

What is the current share price of Sunshine Biopharma Inc (SBFM) Today?

The share price of Sunshine Biopharma Inc (SBFM) is $1.14 (NASDAQ) as of 04-Sep-2026 16:16 EDT. Sunshine Biopharma Inc (SBFM) has given a return of -76.11% in the last 3 years.

What is the current PB & PE ratio of Sunshine Biopharma Inc (SBFM)?

Since, TTM earnings of Sunshine Biopharma Inc (SBFM) is negative, P/E ratio is not available.
The P/B ratio of Sunshine Biopharma Inc (SBFM) is 0.18 times as on 28-Aug-2026, a 98 discount to its peers’ median range of 7.69 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-0.10	0.03
2024	-1.51	0.33
2023	0.00	0.00
2022	-0.05	0.07
2021	0.00	0.10

What is the 52 Week High and Low of Sunshine Biopharma Inc (SBFM)?

The 52-week high and low of Sunshine Biopharma Inc (SBFM) are Rs 30.42 and Rs 1.01 as of 06-Sep-2026.

What is the market cap of Sunshine Biopharma Inc (SBFM)?

Sunshine Biopharma Inc (SBFM) has a market capitalisation of $ 4 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Sunshine Biopharma Inc (SBFM)?

Before investing in Sunshine Biopharma Inc (SBFM), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.